Upcoming Events
Log In
Pricing
Free Trial

Central Neuro, Pediatricscytoma

HIDE
PrevNext

0:00

Hello, welcome back to Pro Scan MRI Online.

0:02

My name is Dr. Benjamin Laser,

0:04

neuroradiologist,

0:05

and we are going to continue our case discussion

0:07

on non-glial CNS brain tumors.

0:09

This patient is a 43-year- old woman who presents

0:12

with headache, and as you can see,

0:14

there is a well-defined smooth lobulated mass within

0:18

the right lateral ventricle.

0:20

On T2-weighted imaging,

0:22

the mass is usually heterogeneous with the soft tissue

0:25

solid components being isointense

0:26

to adjacent brain parenchyma.

0:28

The cysts are hypointense on the T2-weighted sequence.

0:32

In the center panel,

0:33

the cysts are hyperintense and the mass soft tissue

0:36

is isointense to adjacent brain parenchyma.

0:38

And on the far right panel, our FLAIR sequence,

0:41

the mass typically has heterogeneous appearance

0:44

and hyperintense to adjacent brain parenchyma.

0:47

These findings are most consistent with the central

0:49

neurocytoma. After contrast is administered,

0:51

these lesions have moderate to strong

0:54

heterogeneous enhancement.

0:55

Calcification is a common finding in these lesions and the

0:58

calcification would be hyperintense on T2 weighted

1:00

sequence or have blooming artifacts on T2* sequence.

1:03

If spectroscopy was performed,

1:04

these lesions have elevated choline

1:06

peak and decreased NAA peaks.

1:10

The glycine peak can be seen at 3.5 parts per million

1:13

and the alanine peak is variable FDG PET imaging.

1:16

These lesions have hypometabolism and MRI is the most

1:21

sensitive examination to evaluate these lesions.

1:24

Central neurocytoma are usually located

1:27

within the lateral ventricles.

1:29

About 50% of the time in the frontal horn or body of

1:33

the lateral ventricle near the foramen of Monro.

1:35

15% of the time these lesions extend to the third

1:38

ventricle and they can be seen in both outer ventricles,

1:41

about 13% of the time and only about 5% of the time.

1:44

They can be seen isolated to the third ventricle.

1:47

They have rare extraventricular extension and

1:50

the size can be variable as described.

1:53

The morphology is typical for a circumscribed

1:56

mass with lobulated margins,

1:58

intraoral cysts and a bubbly appearance

2:00

on imaging studies.

2:02

These tumors likely arise from neuroglial or bipotential

2:04

progenitor cells. Perronova is extremely rare,

2:07

and they are considered a WHO grade two

2:11

lesion.

2:12

The most common signs and symptoms for these tumors

2:16

include headache, increased intracranial pressure,

2:19

mental status changes and even seizure.

2:21

Other signs and symptoms include hydrocephalus,

2:24

secondary to obstruction as these masses can typically

2:27

be seen at the foramen of Monro causing

2:30

obstructive hydrocephalus.

2:31

If the tumor is isolated to the third

2:33

ventricle or near the hypothalamus,

2:35

these patients can present with visual disturbances

2:37

or even hormonal dysfunction.

2:38

Central neurocytoma are rarely asymptomatic.

2:41

They occur in young adults ages 20 to 40 years,

2:44

approximately 70% of the time, the mean age is 29 years.

2:47

There is no gender predilection.

2:50

These account for less than 1% of all

2:52

primary intracranial neoplasms.

2:54

These tumors represent 50% of intraventricular

2:56

tumors in patients 20 to 40 years of age.

2:59

Central neurocytoma are benign tumors

3:01

and local recurrence is uncommon.

3:03

They are rarely complicated by hemorrhage

3:06

and CSF dissemination is extremely rare.

3:08

Complete surgical resection is the treatment of choice.

3:11

And if the surgical resection is incomplete,

3:13

additional treatment would include radiation therapy,

3:16

chemotherapy, and or radiosurgery.

3:19

Differential diagnosis for these tumors would include

3:22

subependymoma which could be indistinguishable

3:25

from a central neurocytoma.

3:27

If the central neurocytoma is small

3:29

and more solid appearing, however,

3:31

subependymomas usually occur in older patients

3:34

and have very faint to no enhancement,

3:36

and the location helps differentiate the diagnosis.

3:41

Subependymomas usually happen in the fourth ventricle

3:43

much greater than the lateral ventricle.

3:45

Another differential diagnosis would include

3:48

suboptimal giant cell astrocytoma.

3:50

These tumors usually arise near the foramen of Monroe;

3:54

calcification is extremely common. However,

3:57

there would be many additional findings for the stigmata

4:00

of tuberous sclerosis, such as subependymal nodules,

4:03

cortical tumors, or white matter lesions.

4:06

Another differential could be an intraventricular

4:09

metastasis. However, those are extremely uncommon,

4:11

and those would be in an older population.

4:14

The primary tumor is usually known

4:16

for intraventricular metastasis.

4:18

Another differential consideration would

4:20

include choroid plexus papilloma.

4:22

These lesions are usually in younger patients within the

4:25

lateral ventricle but predominantly

4:26

within the fourth ventricle.

4:28

They are intensely enhancing with papillary

4:30

or frothy-like projections,

4:32

and hydrocephalus is extremely common

4:34

with a choroid plexus papilloma.

4:36

Meningioma is also another differential consideration.

4:39

These tumors are circumscribed, intensely enhancing,

4:43

and usually at the trigone of the lateral ventricle.

4:46

Again,

4:46

age is a very important discriminator

4:48

when describing these lesions,

4:51

and intraventricular meningiomas usually happen in the

4:54

older population. So take-home points for this lesion:

4:57

when you see a lesion within the ventricle,

4:59

that is well-defined intraventricular cysts, bubbly,

5:04

feathery near the septum pellucidum or attached to

5:07

the septum pellucidum, think central neurocytoma.

Report

Description

Faculty

Stephen J Pomeranz, MD

Chief Medical Officer, ProScan Imaging. Founder, MRI Online

ProScan Imaging

Tags

Pediatrics

Neuroradiology

Neoplastic

MRI

Brain

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy